National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 01:52:38

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0056-0172-01	EA - Each	0056-0172	5c1933c8-6e8e-41ff-836c-fe46351016ee	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0056-0172	0056-0172-01

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N009218-005	COUMADIN	WARFARIN SODIUM	10MG	TABLET / ORAL	RLD, Approved before 1982
N009218-007	COUMADIN	WARFARIN SODIUM	5MG	TABLET / ORAL	RLD, Approved before 1982
N009218-012	COUMADIN	WARFARIN SODIUM	75MG/VIAL	INJECTABLE / INJECTION	Approved before 1982
N009218-013	COUMADIN	WARFARIN SODIUM	2MG	TABLET / ORAL	RLD, Approved before 1982
N009218-016	COUMADIN	WARFARIN SODIUM	7.5MG	TABLET / ORAL	RLD, Approved before 1982
N009218-018	COUMADIN	WARFARIN SODIUM	2.5MG	TABLET / ORAL	RLD, Approved before 1982
N009218-020	COUMADIN	WARFARIN SODIUM	50MG/VIAL	INJECTABLE / INJECTION	Approved before 1982
N009218-022	COUMADIN	WARFARIN SODIUM	1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1990-03-01
N009218-023	COUMADIN	WARFARIN SODIUM	4MG	TABLET / ORAL	RLD	1993-08-24
N009218-024	COUMADIN	WARFARIN SODIUM	5MG/VIAL	INJECTABLE / INJECTION		1995-02-07
N009218-025	COUMADIN	WARFARIN SODIUM	3MG	TABLET / ORAL	RLD	1996-11-18
N009218-026	COUMADIN	WARFARIN SODIUM	6MG	TABLET / ORAL	RLD	1996-11-18

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 13 · 516 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N009218-005	COUMADIN	10MG	TABLET / ORAL	RLD, Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N009218-007	COUMADIN	5MG	TABLET / ORAL	RLD, Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N009218-012	COUMADIN	75MG/VIAL	INJECTABLE / INJECTION	Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N009218-013	COUMADIN	2MG	TABLET / ORAL	RLD, Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N009218-016	COUMADIN	7.5MG	TABLET / ORAL	RLD, Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N009218-018	COUMADIN	2.5MG	TABLET / ORAL	RLD, Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N009218-020	COUMADIN	50MG/VIAL	INJECTABLE / INJECTION	Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N009218-022	COUMADIN	1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1990-03-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N009218-023	COUMADIN	4MG	TABLET / ORAL	RLD	1993-08-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N009218-024	COUMADIN	5MG/VIAL	INJECTABLE / INJECTION		1995-02-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N009218-025	COUMADIN	3MG	TABLET / ORAL	RLD	1996-11-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N009218-026	COUMADIN	6MG	TABLET / ORAL	RLD	1996-11-18	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N009218-005	COUMADIN	10MG	TABLET / ORAL	RLD, Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N009218-007	COUMADIN	5MG	TABLET / ORAL	RLD, Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N009218-012	COUMADIN	75MG/VIAL	INJECTABLE / INJECTION	Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N009218-013	COUMADIN	2MG	TABLET / ORAL	RLD, Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N009218-016	COUMADIN	7.5MG	TABLET / ORAL	RLD, Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N009218-018	COUMADIN	2.5MG	TABLET / ORAL	RLD, Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N009218-020	COUMADIN	50MG/VIAL	INJECTABLE / INJECTION	Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N009218-022	COUMADIN	1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1990-03-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N009218-023	COUMADIN	4MG	TABLET / ORAL	RLD	1993-08-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N009218-024	COUMADIN	5MG/VIAL	INJECTABLE / INJECTION		1995-02-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N009218-025	COUMADIN	3MG	TABLET / ORAL	RLD	1996-11-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N009218-026	COUMADIN	6MG	TABLET / ORAL	RLD	1996-11-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N009218-005	COUMADIN	10MG	TABLET / ORAL	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N009218-007	COUMADIN	5MG	TABLET / ORAL	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N009218-012	COUMADIN	75MG/VIAL	INJECTABLE / INJECTION	Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N009218-013	COUMADIN	2MG	TABLET / ORAL	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N009218-016	COUMADIN	7.5MG	TABLET / ORAL	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N009218-018	COUMADIN	2.5MG	TABLET / ORAL	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N009218-020	COUMADIN	50MG/VIAL	INJECTABLE / INJECTION	Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N009218-022	COUMADIN	1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1990-03-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N009218-023	COUMADIN	4MG	TABLET / ORAL	RLD	1993-08-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N009218-024	COUMADIN	5MG/VIAL	INJECTABLE / INJECTION		1995-02-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N009218-025	COUMADIN	3MG	TABLET / ORAL	RLD	1996-11-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N009218-026	COUMADIN	6MG	TABLET / ORAL	RLD	1996-11-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N009218-005	COUMADIN	10MG	TABLET / ORAL	RLD, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N009218-007	COUMADIN	5MG	TABLET / ORAL	RLD, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N009218-012	COUMADIN	75MG/VIAL	INJECTABLE / INJECTION	Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N009218-013	COUMADIN	2MG	TABLET / ORAL	RLD, Approved before 1982		`31067a03dcf5…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N009218-005	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N009218-007	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N009218-013	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N009218-016	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N009218-018	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N009218-022	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N009218-023	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N009218-025	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N009218-026	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N009218-005	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N009218-007	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N009218-013	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N009218-016	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N009218-018	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N009218-022	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N009218-023	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N009218-025	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N009218-026	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N009218-005	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N009218-007	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N009218-013	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N009218-016	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N009218-018	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N009218-022	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N009218-023	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N009218-025	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N009218-026	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N009218-005	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N009218-007	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N009218-013	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N009218-016	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N009218-018	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N009218-022	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N009218-023	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N009218-025	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N009218-026	AB	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.